| Literature DB >> 36003941 |
Jiao-Yun Jiang1,2,3, Wen-Hong Li1,4, Yang-Yang Wu3, Chun-Xing Cheng3, Quan-Qing Ye3, Jia-Xun Feng1, Zhi-Xun Xie1,2.
Abstract
As one of the most environmentally toxic heavy metals, cadmium (Cd) has attracted the attention of researchers globally. In particular, Guangxi, a province in southwestern China, has been subjected to severe Cd pollution due to geogenic processes and anthropogenic activities. Cd can be accumulated in aquatic animals and transferred to the human body through the food chain, with potential health risks. The aim of the present study was to explore the effects of waterborne Cd exposure (0.5 mg/L and 1.5 mg/L) on the intestinal microbiota of mudsnail, Cipangopaludina cathayensis, which is favored by farmers and consumers in Guangxi. Gut bacterial community composition was investigated using high-throughput sequencing of the V3-V4 segment of the bacterial 16S rRNA gene. Our results indicated that C. cathayensis could tolerate low Cd (0.5 mg/L) stress, while Cd exposure at high doses (1.5 mg/L) exerted considerable effects on microbiota composition. At the phylum level, Proteobacteria, Bacteroidetes, and Firmicutes were the dominant phyla in the mudsnail gut microbiota. The relative abundances of Bacteroidetes increased significantly under high Cd exposure (H14) (p < 0.01), with no significant change in the low Cd exposure (L14) treatment. The dominant genera with significant differences in relative abundance were Pseudomonas, Cloacibacterium, Acinetobacter, Dechloromonas, and Rhodobacter. In addition, Cd exposure could significantly alter the pathways associated with metabolism, cellular processes, environmental information processing, genetic information processing, human diseases, and organismal systems. Notably, compared to the L14 treatment, some disease-related pathways were enriched, while some xenobiotic and organic compound biodegradation and metabolism pathways were significantly inhibited in the H14 group. Overall, Cd exposure profoundly influenced community structure and function of gut microbiota, which may in turn influence C. cathayensis gut homeostasis and health.Entities:
Keywords: Cipangopaludina cathayensis; cadmium; high-throughput sequencing; intestinal microbiota; microbial diversity
Year: 2022 PMID: 36003941 PMCID: PMC9393624 DOI: 10.3389/fmicb.2022.984757
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 6.064
FIGURE 1Venn diagram analysis depicting the numbers of shared and unique Amplicon Sequence Variants (ASVs) among the control (CK14), 0.5 mg/L (L14), and H14 (1.5 mg/L) treatments.
FIGURE 2Intestinal microbiome diversity in the control (CK14), 0.5 mg/L (L14) and H14 (1.5 mg/L) groups. (A) α-diversity comparisons in the intestinal microflora among the CK14, L14, and H14 groups. (B) Bray–Curtis distances were calculated and visualized through Principal Coordinate Analysis (PCoA) (Ellipses were drawn with 95% confidence intervals). (C) Hierarchical cluster analysis of the Bray–Curtis distances generated from taxa tables showed Amplicon Sequence Variant (ASV) similarity across microbial communities among different groups.
FIGURE 3Compositions of the intestinal microflora among the control (CK14), 0.5 mg/L (L14), and H14 (1.5 mg/L) treatments. (A) Compositions of the intestinal microflora at the phylum level. (B) Compositions of the intestinal microflora at the genus level. The top ten abundant genera (higher than 1% in at least one sample) are shown in the figure and the rest are indicated as “Others.”
FIGURE 4Functional annotations and abundance information about the intestinal microbiota at KEGG level 1 and level 2. The gene function is showed as color-bars (level 1). The detailed pathways are shown on the left side (level 2).
FIGURE 5Intestinal microbiota predictive metabolic functions from the Kyoto Encyclopedia of Genes and Genomes (KEGG) database in all samples. (A) Heatmap of the significant differential pathways among the control (CK14), 0.5 mg/L (L14), and H14 (1.5 mg/L) treatments. (B) Significant different pathways between the control and L14 treatments. (C) Significantly different pathways between the control and H14 treatments. (D) Significantly different pathways between the L14 and H14 treatments.